Plasminogen Activator Inhibitor-1 Regulates Tumor Growth and Angiogenesis
Open Access
- 1 September 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (36), 33964-33968
- https://doi.org/10.1074/jbc.m105980200
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1Journal of Biological Chemistry, 2001
- Urokinase-type Plasminogen Activator Receptor (CD87) Is a Ligand for Integrins and Mediates Cell-Cell InteractionJournal of Biological Chemistry, 2001
- Antiangiogenic Activity of the Cleaved Conformation of the Serpin AntithrombinScience, 1999
- Plasminogen Activator Inhibitor-1 Contains a Cryptic High Affinity Binding Site for the Low Density Lipoprotein Receptor-related ProteinJournal of Biological Chemistry, 1998
- Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell MigrationJournal of Biological Chemistry, 1996
- Regulation of Integrin Function by the Urokinase ReceptorScience, 1996
- Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.Journal of Clinical Investigation, 1995
- Physiological consequences of loss of plasminogen activator gene function in miceNature, 1994
- Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancerThe Lancet, 1994
- Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.Journal of Clinical Investigation, 1993